Liu Lin, Chen Chao-Lei, Lo Kenneth, Huang Jia-Yi, Yu Yu-Ling, Huang Yu-Qing, Feng Ying-Qing
Department of Cardiology, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of Coronary Heart Disease Prevention, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510080, People's Republic of China.
Centre for Global Cardiometabolic Health, Department of Epidemiology, Brown University, Providence, RI, USA.
Int J Gen Med. 2020 Sep 14;13:599-608. doi: 10.2147/IJGM.S267346. eCollection 2020.
Little is known about the recent trends of hypertension in southern China. The aim of the study was to investigate the trends of hypertension in Guangdong Province between 2012 and 2019.
We conducted two cross-sectional surveys in 2012 and 2019 in southern China, which included 10,970 and 27,483 participants, respectively, aged 35 to 75 years old using a method of stratified, multistage, and cluster sampling. Hypertension was defined as a mean systolic/diastolic blood pressure (SBP/DBP) ≥140/90mmHg, or a self-reported condition, or any pharmacological treatment in the last 2 weeks. In addition, according to the 2017 ACC/AHA guideline for high blood pressure, we estimated the prevalence and control rate of hypertension.
According to the 2010 Chinese guideline, the age-standardized rate of hypertension prevalence was 34.7% in 2012 and 36.9% in 2019 with a slight increase, while the prevalence of prehypertension was stable (14.5% vs 14.3%). Over the period of our study, 45.6% and 60.7% of hypertensive patients knew their diagnosis in 2012 and 2019, and 40.8% and 51.5% were using antihypertensive medications, respectively. The control rates increased from 15.1% to 23.6%. Hypertension prevalence was 64.5% in 2012 and 63.2% in 2019, and the control rate increased from 3.0% to 4.8% during the study period under the 2017 ACC/AHA guideline.
Although the past 7 years have seen some progress in hypertension management, the rates of hypertension awareness, treatment, and control in southern Chinese remained regrettably low, and the prevalence rate was still high.
对中国南方地区高血压的近期趋势了解甚少。本研究旨在调查2012年至2019年广东省高血压的趋势。
我们于2012年和2019年在中国南方进行了两次横断面调查,分别纳入了10970名和27483名年龄在35至75岁之间的参与者,采用分层、多阶段和整群抽样方法。高血压定义为平均收缩压/舒张压(SBP/DBP)≥140/90mmHg,或自我报告的疾病,或过去2周内的任何药物治疗。此外,根据2017年美国心脏病学会/美国心脏协会高血压指南,我们估算了高血压的患病率和控制率。
根据2010年中国指南,2012年高血压患病率的年龄标准化率为34.7%,2019年为36.9%,略有上升,而高血压前期患病率稳定(分别为14.5%和14.3%)。在我们的研究期间,2012年和2019年分别有45.6%和60.7%的高血压患者知晓自己的诊断,分别有40.8%和51.5%的患者正在使用降压药物。控制率从15.1%提高到了23.6%。根据2017年美国心脏病学会/美国心脏协会指南,2012年高血压患病率为64.5%,2019年为63.2%,研究期间控制率从3.0%提高到了4.8%。
尽管过去7年高血压管理取得了一些进展,但中国南方地区高血压的知晓率、治疗率和控制率仍低得令人遗憾,患病率仍然很高。